“Promising” initial results for sirolimus-eluting bioresorbable scaffold in DESappear trial


DESappear Andrew Holden

The sirolimus-eluting bioresorbable peripheral scaffold system (Prava; Elixir Medical) is designed to treat stenoses and occlusion in the superficial femoral artery. Prava was first implanted in October 2016 and will be clinically evaluated in the DESappear trial that has currently enrolled 21 patients at 11 […]